Preparation and pharmacological evaluation of captopril sustained-release dosage forms using oily semisolid matrix
Authors:
- Toshie OtsukaTOToshie Otsuka
- 1 February 1988
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 41 (3) , 255-262
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Design and preparation of captopril sustained-release dosage forms and their biopharmaceutical propertiesInternational Journal of Pharmaceutics, 1988
- Captopril: pharmacokinetics, antihypertensive and biological effects in hypertensive patients.British Journal of Clinical Pharmacology, 1984
- Relationship between inhibition of pressor response to angiotensin I and blood concentration of captopril following a single oral administration to dogsEuropean Journal of Pharmacology, 1981
- Determination of captopril in blood and urine by high-performance liquid chromatography.Chemical and Pharmaceutical Bulletin, 1981
- The in vitro loss of penicillamine in plasma, albumin solutions, and whole blood: Implications for pharmacokinetic studies of penicillamineLife Sciences, 1980
- Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.Hypertension, 1980
- Compensation of dietary induced reduction of tetracycline absorption by simultaneous administration of EDTAEuropean Journal of Clinical Pharmacology, 1978
- Influence of Food on the Bioavailability of DrugsClinical Pharmacokinetics, 1978
- Elevation of serum angiotension-converting-enzyme (ACE) level in sarcoidosisThe American Journal of Medicine, 1975
- Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lungBiochemical Pharmacology, 1971